44 results on '"Bruzek, Amy"'
Search Results
2. Medulloblastoma
3. Complications of the Occult Spinal Dysraphisms
4. Middle Fossa Arachnoid Cyst
5. Supplementary Table S3A and S3B from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
6. Supplementary Data from Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
7. Ultra-rapid somatic variant detection via real-time targeted amplicon sequencing
8. Robot-Assisted Minimally Invasive Sacroiliac Joint Fusion for Sacroiliac Joint Dysfunction: 2-Dimensional Operative Video
9. Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma
10. CHFR and Paclitaxel Sensitivity of Ovarian Cancer
11. BIOM-28. SERIAL PLASMA AND CSF CELL-FREE TUMOR DNA (cf-tDNA) TRACKING IN DIFFUSE MIDLINE GLIOMA PATIENTS UNDERGOING TREATMENT WITH ONC201
12. EPCT-03. SERIAL PLASMA AND CSF CELL-FREE TUMOR DNA (CF-TDNA) TRACKING IN DIFFUSE MIDLINE GLIOMA PATIENTS UNDERGOING TREATMENT WITH ONC201
13. Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.
14. DIPG-08. ELECTRONIC SEQUENCING PROVIDES OPTIMIZED QUANTIFICATION OF SERIAL, MULTI-GENE MOLECULAR RESPONSE IN THE CSF OF CHILDREN WITH HIGH-GRADE GLIOMA
15. Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma
16. HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA
17. CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA
18. Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma
19. Posterior Cranial Vault Distraction Osteogenesis: Routine Low Occipital Craniotomy Is a Safe Approach That Optimizes Outcomes
20. Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma
21. Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
22. Syringomyelia in children with closed spinal dysraphism: long-term outcomes after surgical intervention
23. Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
24. Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma
25. PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA
26. PDTM-10. USE OF A NOVEL, HAND-HELD, ELECTRONIC DNA ANALYSIS PLATFORM TO QUANTIFY MULTI-GENE MOLECULAR RESPONSE IN CSF OF PATIENTS WITH HIGH-GRADE GLIOMA
27. Morphometric changes at the craniocervical junction during childhood
28. The effect of everolimus on CNS penetration and efficacy of dasatinib in the treatment of PDGFRA-driven glioma.
29. DIPG-06. RAPID, ULTRA-DEEP SEQUENCING OF PEDIATRIC DIPG FROM CEREBROSPINAL FLUID USING A NOVEL HAND-HELD ELECTRONIC DNA ANALYSIS PLATFORM
30. HGG-04. USE OF AN ADVANCED RNA-SEQ FUSION PIPELINE RESULTS IN THE TARGETED TREATMENT AND SUSTAINED CLINICAL RESPONSE OF CHILDREN WITH RECURRENT PEDIATRIC HIGH-GRADE GLIOMA
31. HGG-03. EVEROLIMUS TREATMENT IMPROVES THE CNS PENETRATION AND EFFICACY OF DASATINIB IN THE TREATMENT OF PDGFRA-DRIVEN PEDIATRIC HIGH-GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA
32. Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations
33. PDTM-29. CSF H3F3A K27M CIRCULATING TUMOR DNA COPY NUMBER QUANTIFIES TUMOR GROWTH AND TREATMENT RESPONSE
34. CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response
35. The Preventable Shunt Revision Rate: A Multicenter Evaluation
36. Molecular characterization reveals NF1 deletions and FGFR1‐activating mutations in a pediatric spinal oligodendroglioma
37. MPTH-21. MOLECULAR CHARACTERIZATION REVEALS NF1 LOSS AND FGFR1 ACTIVATING MUTATIONS IN PEDIATRIC SPINAL OLIGODENDROGLIOMA
38. Intramedullary and Extramedullary Cervical Neurenteric Cyst Requiring Fixation and Fusion
39. Pilocytic Astrocytoma Presenting as an Orbital Encephalocele: A Case Report
40. Extracorporeal Membrane Oxygenation Support as a Life-saving Measure for Acute Respiratory Distress Syndrome After Craniectomy
41. Control of Centrin Stability by Aurora A
42. A promising approach for treatment of tumor-induced bone diseases: Utilizing bisphosphonate derivatives of nucleoside antimetabolites
43. Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response
44. Aurora A and B Overexpression and Centrosome Amplification in Early Estrogen-Induced Tumor Foci in the Syrian Hamster Kidney: Implications for Chromosomal Instability, Aneuploidy, and Neoplasia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.